Table 3. Multiple logistic regression for EGFR mutation in lung adenocarcinoma patients (n = 6483).
| EGFR Mutation | EGFR Wild-type | Odds ratio* | P value | |
|---|---|---|---|---|
| Gender, n (%) | ||||
| Male | 1586 (40.7) | 1511 (58.4) | 1.00 (reference) | |
| Female | 2311 (59.3) | 1075 (41.6) | 1.19 (1.04–1.36) | < .001 |
| Age, n (%) | ||||
| ≦ 45 years old | 213 ( 5.5) | 193 ( 7.5) | 1.00 (reference) | |
| > 45 years old | 3684 (94.5) | 2393 (92.5) | 1.38 (1.12–1.69) | 0.001 |
| Stage, n (%) | ||||
| I–IIIA | 635 (16.3) | 378 (14.6) | 1.00 (reference) | |
| IIIB–IV | 3262 (83.7) | 2208 (85.4) | 0.95 (0.82–1.09) | 0.068 |
| Smoking history, n (%) | ||||
| Never smoker | 2878 (73.9) | 1323 (51.2) | 1.00 (reference) | |
| Ever smoker | 1019 (26.1) | 1263 (48.4) | 0.42 (0.36–0.48) | < .001 |
Abbreviations: EGFR, epidermal growth factor receptor.
Odds ratios for EGFR mutation.